Otoferlin Gene-mediated Hearing Loss
·MeSH: Hearing Loss
Prevalence
5000.0 / 100K
Incidence
400.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Otoferlin Gene-mediated Hearing Loss?
There are 1 clinical trial targeting Otoferlin Gene-mediated Hearing Loss tracked by BioSniper.
What is the prevalence of Otoferlin Gene-mediated Hearing Loss?
The estimated prevalence of Otoferlin Gene-mediated Hearing Loss is approximately 5000.0 per 100,000 population.
Deep-dive into Otoferlin Gene-mediated Hearing Loss
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis